[1] Mardi T, Toker S, Melamed S, et al. Increased erythropoiesis and subclinical inflammation as part of the metabolic syndrome [J]. Diabetes Res Clin Pract, 2005, 69(3):249-255. [2] Alberti K G, Eckel R H, Grundy S M, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity [J]. Circulation, 2009, 120(16): 1640-1645. [3] Chen C, Lu F C. Department of disease control ministry of health, PR china. The guidelines for prevention and control of overweight and obesity in Chinese adults [J]. Biomed Environ Sci, 2004, 17 Suppl: 1-36. [4] Laudisio A, Bandinelli S, Gemma A, et al. Metabolic syndrome and hemoglobin levels in elderly adults: the Invecchiare in Chianti Study [J]. J Am Geriatr Soc, 2013, 61(6):963-968. [5] Kawamoto R, Tabara Y, Kohara K, et al. Hematological parameters are associated with metabolic syndrome in Japanese community-dwelling persons [J]. Endocrine, 2013, 43(2): 334-341. [6] Zinchuk V V, Pronko T P, Lis M A. Blood oxygen transport and endothelial dysfunction in patients with arterial hypertension [J]. Clin Physiol Funct Imaging, 2004, 24(4): 205-211. [7] Schiffrin E L.Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation [J]. Hypertension, 2008, 51(1):31-32. [8] Kelm M, Rath J. Endothelial dysfunction in human coronary circulation: relevance of the L-arginine-NO pathway [J]. Basic Res Cardiol, 2001, 96(2):107-127. [9] Singel D J, Stamler J S. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin [J]. Annu Rev Physiol, 2005, 67:99-145. [10] Kutlu M, Sonmez A, Genc H, et al. Relationship between hemoglobin and CD40 ligand in prediabetes [J]. Clin Invest Med, 2009, 32(6):E244. [11] 程千鹏,张星光,吕肖锋. 血糖控制达标的2型糖尿病患者血糖波动特征及其控制目标探讨[J]. 解放军医药杂志,2013,25(11):24-27. [12] 孟馨,贾楠,金智一,等. 2型糖尿病患者血清CA-125水平与代谢控制指标的相关性研究[J]. 中国医科大学学报,2014,43(11):996-998,1002. [13] Shimizu Y, Nakazato M, Sekita T, et al. Association between the hemoglobin levels and hypertension in relation to the BMI status in a rural Japanese population: the Nagasaki Islands Study [J]. Intern Med, 2014, 53(5):435-440. [14] 杨伟. 抵抗素与老年糖尿病合并高血压的相关性研究[J]. 临床误诊误治,2013,26(12):69-71. [15] 杨长卫,马鹏飞,张建祥. 二甲双胍对2型糖尿病大血管病变的防治研究进展[J]. 临床误诊误治,2014,27(1):107-111. |